IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (TH17) cells in the periphery

Journal of Clinical Immunology

Volumn 30, Issue 5, 2010, Pages 681-692

  Ndhlovu, Lishomwa C ^a   Sinclair, Elizabeth ^a   Epling, Lorrie ^a   Tan, Qi Xuan ^a   Ho, Terence ^a   Jha, Aashish R ^a   Eccles James, Ijeoma ^a   Tincati, Camilla ^a   Levy, Jay A ^a   Nixon, Douglas F ^a   Hecht, Frederick M ^a   Barbour, Jason D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anti retroviral therapy; cytokines; HIV 1; Human; interleukin 17; interleukin 2; T cells; T regs

Indexed keywords

ANTIRETROVIRUS AGENT; CD28 ANTIGEN; CD3 ANTIGEN; CYTOMEGALOVIRUS ANTIGEN PP65; GAG PROTEIN; INTERLEUKIN 17; INTERLEUKIN 2; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; TH17 CELL;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL PROLIFERATION; DRUG THERAPY, COMBINATION; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOMODULATION; IMMUNOTHERAPY; INTERLEUKIN-17; INTERLEUKIN-2; PHOSPHOPROTEINS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; TH17 CELLS; VIRAL MATRIX PROTEINS;

EID: 77957571862     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9432-3     Document Type: Article

References (62)

1. A Amadi-Obi CR Yu X Liu RM Mahdi GL Clarke RB Nussenblatt, et al. 2007 TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 Nat Med 13 711 718 10.1038/nm1585 17496900 1:CAS:528:DC%2BD2sXmtFeks7c%3D (Pubitemid 46889754)
2. I Kryczek S Wei L Vatan J Escara-Wilke W Szeliga ET Keller, et al. 2007 Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression J Immunol 179 1423 1426 17641006 1:CAS:528:DC%2BD2sXnvVyntr0%3D
3. I Kryczek S Wei L Zou S Altuwaijri W Szeliga J Kolls, et al. 2007 Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment J Immunol 178 6730 6733 17513719 1:CAS:528: DC%2BD2sXlsVOnt7s%3D
4. LC Ndhlovu JM Chapman AR Jha JE Snyder-Cappione M Pagan FE Leal, et al. 2008 Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection Aids 22 990 992 10.1097/QAD. 0b013e3282ff884e 18453860 1:CAS:528:DC%2BD1cXltl2ju7k%3D (Pubitemid 351652251)
5. FY Yue A Merchant CM Kovacs M Loutfy D Persad MA Ostrowski 2008 Virus-specific interleukin-17-producing CD4+ T cells are detectable in early human immunodeficiency virus type 1 infection J Virol 82 6767 6771 10.1128/JVI.02550-07 18434403 1:CAS:528:DC%2BD1cXnslyqtLo%3D (Pubitemid 351875153)
6. JD Milner JM Brenchley A Laurence AF Freeman BJ Hill KM Elias, et al. 2008 Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome Nature 452 773 776 10.1038/nature06764 18337720 1:CAS:528:DC%2BD1cXksFSisr8%3D (Pubitemid 351521078)
7. L Steinman 2008 A rush to judgment on Th17 J Exp Med 205 1517 1522 10.1084/jem.20072066 18591407 1:CAS:528:DC%2BD1cXosVKktrg%3D (Pubitemid 351962013)
8. D Favre S Lederer B Kanwar ZM Ma S Proll Z Kasakow, et al. 2009 Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection PLoS Pathog 5 e1000295 10.1371/journal.ppat.1000295 19214220 1:CAS:528:DC%2BD1MXisFyntL8%3D
9. Prendergast A, Prado JG, Kang YH, Chen F, Riddell LA, Luzzi G, et al. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. Aids. 24:491-502.
10. El Hed A, Khaitan A, Kozhaya L, Manel N, Daskalakis D, Borkowsky W, et al. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis. 201:843-54.
11. M Macal S Sankaran TW Chun E Reay J Flamm TJ Prindiville, et al. 2008 Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses Mucosal Immunol 1 475 488 10.1038/mi.2008.35 19079215 1:CAS:528:DC%2BD1cXht1CmsL%2FK
12. M Kader X Wang M Piatak J Lifson M Roederer R Veazey, et al. 2009 Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection Mucosal Immunol 2 439 449 10.1038/mi.2009.90 19571800 1:CAS:528:DC%2BD1MXpvFygs74%3D
13. Brenchley JM, Paiardini M, Knox KS, Asher AI, Cervasi B, Asher TE, et al. Differential Th17 CD4 T cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008.
14. SJ Aujla PJ Dubin JK Kolls 2007 Th17 cells and mucosal host defense Semin Immunol 19 377 382 10.1016/j.smim.2007.10.009 18054248 1:CAS:528: DC%2BD1cXisVSrsLk%3D (Pubitemid 351274047)
15. M Raffatellu RL Santos DE Verhoeven MD George RP Wilson SE Winter, et al. 2008 Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut Nat Med 14 421 428 10.1038/nm1743 18376406 1:CAS:528:DC%2BD1cXktl2isLg%3D (Pubitemid 351499394)
16. A Laurence CM Tato TS Davidson Y Kanno Z Chen Z Yao, et al. 2007 Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation Immunity 26 371 381 10.1016/j.immuni.2007.02.009 17363300 1:CAS:528: DC%2BD2sXjvVSnsL8%3D (Pubitemid 46413906)
17. A Arno L Ruiz M Juan A Jou M Balague MK Zayat, et al. 1999 Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with
18. C Katlama G Carcelain C Duvivier C Chouquet R Tubiana M De Sa, et al. 2002 Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study-ANRS 082 Aids 16 2027 2034 10.1097/00002030-200210180-00007 12370501 1:CAS:528:DC%2BD38Xns1CmtrY%3D (Pubitemid 35205266)
19. CE Farel DG Chaitt BK Hahn JA Tavel JA Kovacs MA Polis, et al. 2004 Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection Blood 103 3282 3286 10.1182/blood-2003-09-3283 14726376 1:CAS:528:DC%2BD2cXjslKgsLg%3D (Pubitemid 38525652)
20. G Marchetti L Meroni S Varchetta V Terzieva A Bandera D Manganaro, et al. 2002 Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment J Infect Dis 186 606 616 10.1086/342479 12195347 1:CAS:528:DC%2BD38XnsVSltbo%3D (Pubitemid 34925532)
21. D David L Nait-Ighil B Dupont J Maral B Gachot J Theze 2001 Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment J Infect Dis 183 730 735 10.1086/318824 11181149 1:CAS:528: DC%2BD3MXhvFeksL0%3D (Pubitemid 32171747)
22. RT Davey Jr DG Chaitt SC Piscitelli M Wells JA Kovacs RE Walker, et al. 1997 Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons J Infect Dis 175 781 789 10.1086/513971 9086130 1:CAS:528:DyaK2sXisFGqsrw%3D
23. P De Paoli S Zanussi C Simonelli MT Bortolin M D'Andrea C Crepaldi, et al. 1997 Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects J Clin Invest 100 2737 2743 10.1172/JCI119819 9389737
24. S Emery WB Capra DA Cooper RT Mitsuyasu JA Kovacs P Vig, et al. 2000 Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease J Infect Dis 182 428 434 10.1086/315736 10915072 1:CAS:528:DC%2BD3cXmvVWgsrw%3D (Pubitemid 30651038)
25. UR Hengge M Goos S Esser V Exner H Dotterer H Wiehler, et al. 1998 Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients Aids 12 F225 F234 10.1097/00002030-199817000-00003 9863864 1:CAS:528: DyaK1MXlt1Gq
26. JA Kovacs S Vogel JM Albert J Falloon RT Davey Jr RE Walker, et al. 1996 Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus N Engl J Med 335 1350 1356 10.1056/NEJM199610313351803 8857018 1:CAS:528:DyaK28XntVensLg%3D (Pubitemid 26360453)
27. JA Kovacs M Baseler RJ Dewar S Vogel RT Davey Jr J Falloon, et al. 1995 Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study N Engl J Med 332 567 575 10.1056/NEJM199503023320904 7646637 1:STN:280: DyaK2M7ktVSlsQ%3D%3D
28. CS Larsen L Ostergard BK Moller MR Buhl 2000 Subcutaneous interleukin-2 in combination with anti-retroviral therapy for treatment of HIV-1-infected subjects Scand J Infect Dis 32 153 160 10.1080/003655400750045259 10826900 1:STN:280:DC%2BD3cvktVKnuw%3D%3D
29. O Witzke T Winterhagen W Reinhardt U Heemann H Grosse-Wilde E Kreuzfelder, et al. 1998 Comparison between subcutaneous and intravenous interleukin-2 treatment in HIV disease J Intern Med 244 235 240 10.1046/j.1365-2796.1998.00365.x 9747746 1:CAS:528:DyaK1cXmtVaqtro%3D (Pubitemid 28389660)
30. Y Levy C Durier R Krzysiek C Rabian C Capitant AS Lascaux, et al. 2003 Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial Aids 17 343 351 10.1097/00002030-200302140-00008 12556688 1:CAS:528: DC%2BD3sXntFWjtw%3D%3D (Pubitemid 36223259)
31. EM Aandahl J Michaelsson WJ Moretto FM Hecht DF Nixon 2004 Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens J Virol 78 2454 2459 10.1128/JVI.78.5.2454- 2459.2004 14963140 1:CAS:528:DC%2BD2cXhs1SltLw%3D (Pubitemid 38228938)
32. AL Kinter M Hennessey A Bell S Kern Y Lin M Daucher, et al. 2004 CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status J Exp Med 200 331 343 10.1084/jem.20032069 15280419 1:CAS:528: DC%2BD2cXmsVCkur8%3D (Pubitemid 39031252)
33. MP Eggena B Barugahare N Jones M Okello S Mutalya C Kityo, et al. 2005 Depletion of regulatory T cells in HIV infection is associated with immune activation J Immunol 174 4407 4414 15778406 1:CAS:528:DC%2BD2MXisVChtL8%3D
34. LC Ndhlovu CP Loo G Spotts DF Nixon FM Hecht 2008 FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection J Leukoc Biol 83 254 262 10.1189/jlb.0507281 17982112 1:CAS:528:DC%2BD1cXhvFaqt7k%3D (Pubitemid 351225605)
35. J Andersson A Boasso J Nilsson R Zhang NJ Shire S Lindback, et al. 2005 The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients J Immunol 174 3143 3147 15749840 1:CAS:528:DC%2BD2MXitVeiurk%3D
36. J Nacsa Y Edghill-Smith WP Tsai D Venzon E Tryniszewska A Hryniewicz, et al. 2005 Contrasting effects of low-dose IL-2 on vaccine-boosted simian immunodeficiency virus (SIV)-specific CD4+ and CD8+ T cells in macaques chronically infected with SIVmac251 J Immunol 174 1913 1921 15699118 1:CAS:528:DC%2BD2MXhtV2rsrk%3D
37. MH Losso WH Belloso S Emery JA Benetucci PE Cahn MC Lasala, et al. 2000 A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3 J Infect Dis 181 1614 1621 10.1086/315430 10823761 1:CAS:528:DC%2BD3cXktlGhtLk%3D (Pubitemid 30387752)
38. RT Davey Jr RL Murphy FM Graziano SL Boswell AT Pavia M Cancio, et al. 2000 Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial Jama 284 183 189 10.1001/jama.284.2.183 10889591 1:CAS:528:DC%2BD3cXlsFSht74%3D
39. I Sereti P Sklar MS Ramchandani SW Read V Aggarwal H Imamichi, et al. 2007 CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation J Infect Dis 196 677 683 10.1086/520087 17674308 1:CAS:528:DC%2BD2sXhtVCqs7vK (Pubitemid 47293848)
40. D Abrams Y Levy MH Losso A Babiker G Collins DA Cooper, et al. 2009 Interleukin-2 therapy in patients with HIV infection N Engl J Med 361 1548 1559 10.1056/NEJMoa0903175 19828532 1:CAS:528:DC%2BD1MXht1OktLbM
41. Sellier P, Lafuente-Lafuente C, Bergmann JF. Interleukin-2 therapy in patients with HIV infection. N Engl J Med. 362:270-1; author reply 271.
42. Tincati C, Meroni L, Bellistri G, et al. Effects of immunoadjuvant therapy with IL-2 in HIV-positive HAART-naive patients in advanced stage of disease: a characterization of the divere immunological responses to IL-2. 11th European AIDS Conference/European AIDS Clinical Society. Madrid, 2007.
43. BO Porter KB Anthony J Shen B Hahn CE Keh F Maldarelli, et al. 2009 Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial Aids 23 203 212 10.1097/QAD.0b013e32831cc114 19098490 1:CAS:528:DC%2BD1cXhsFWku7%2FO
44. SW Read J Higgins JA Metcalf RA Stevens A Rupert MC Nason, et al. 2006 Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy J Acquir Immune Defic Syndr 42 537 544 10.1097/01.qai.0000223027.47456.d0 16837861 1:CAS:528:DC%2BD28Xnt1Oqurc%3D (Pubitemid 44162421)
45. H Valdez R Mitsuyasu A Landay AD Sevin ES Chan J Spritzler, et al. 2003 Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s J Infect Dis 187 320 325 10.1086/346056 12552459 1:CAS:528:DC%2BD3sXhtlKgtbk%3D (Pubitemid 36132648)
46. N Imami GA Hardy MR Nelson S Morris-Jones R Al-Shahi C Antonopoulos, et al. 1999 Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy Clin Exp Immunol 118 78 86 10.1046/j.1365-2249.1999.01012.x 10540163 1:CAS:528:DyaK1MXnt1Crtbc%3D (Pubitemid 29479787)
47. J Yu H Chen H Horton A Bansal JM McElrath R Reichman, et al. 2006 Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection J Med Virol 78 1147 1157 10.1002/jmv.20675 16847956 1:CAS:528:DC%2BD28XptVajtro%3D (Pubitemid 44182230)
48. JD Barbour FM Hecht T Wrin MR Segal CA Ramstead TJ Liegler, et al. 2004 Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection J Infect Dis 190 251 256 10.1086/422036 15216458 1:CAS:528:DC%2BD2cXmsFaqt7Y%3D (Pubitemid 38951963)
49. D Kothe RH Byers SP Caudill GA Satten RS Janssen WH Hannon, et al. 2003 Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence J Acquir Immune Defic Syndr 33 625 634 10.1097/00126334-200308150-00012 12902808 1:CAS:528:DC%2BD3sXlvF2qtbk%3D (Pubitemid 36975851)
50. N Seddiki B Santner-Nanan J Martinson J Zaunders S Sasson A Landay, et al. 2006 Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells J Exp Med 203 1693 1700 10.1084/jem.20060468 16818676 1:CAS:528:DC%2BD28XntVCgs7w%3D (Pubitemid 44036275)
51. W Liu AL Putnam Z Xu-Yu GL Szot MR Lee S Zhu, et al. 2006 CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells J Exp Med 203 1701 1711 10.1084/jem.20060772 16818678 1:CAS:528:DC%2BD28XntVCgs70%3D (Pubitemid 44036276)
52. DA Meiklejohn RK Karlsson AC Karlsson JM Chapman DF Nixon B Schweighardt 2004 ELISPOT cell rescue J Immunol Methods 288 135 147 10.1016/j.jim.2004.03.006 15183092 1:CAS:528:DC%2BD2cXks1WksLY%3D (Pubitemid 38739259)
53. Z Chen JJ O'Shea 2008 Th17 cells: a new fate for differentiating helper T cells Immunol Res 41 87 102 10.1007/s12026-007-8014-9 18172584 1:CAS:528:DC%2BD1cXhtFSrurvL
54. EV Acosta-Rodriguez L Rivino J Geginat D Jarrossay M Gattorno A Lanzavecchia, et al. 2007 Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells Nat Immunol 8 639 646 10.1038/ni1467 17486092 1:CAS:528:DC%2BD2sXlsVSrsLo%3D (Pubitemid 46785128)
55. II Ivanov BS McKenzie L Zhou CE Tadokoro A Lepelley JJ Lafaille, et al. 2006 The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells Cell 126 1121 1133 10.1016/j.cell.2006. 07.035 16990136 1:CAS:528:DC%2BD28XhtVCnsrrE (Pubitemid 44380299)
56. Z Chen CM Tato L Muul A Laurence JJ O'Shea 2007 Distinct regulation of interleukin-17 in human T helper lymphocytes Arthritis Rheum 56 2936 2946 10.1002/art.22866 17763419 1:CAS:528:DC%2BD2sXht1GgtbzE (Pubitemid 47502740)
57. JA Bluestone AK Abbas 2003 Natural versus adaptive regulatory T cells Nat Rev Immunol 3 253 257 10.1038/nri1032 12658273 1:CAS:528:DC%2BD3sXitleqtLg%3D (Pubitemid 37323210)
58. X Hu LB Ivashkiv 2009 Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases Immunity 31 539 550 10.1016/j.immuni.2009.09.002 19833085 1:CAS:528: DC%2BD1MXhsVChtL3L
59. MA Koch G Tucker-Heard NR Perdue JR Killebrew KB Urdahl DJ Campbell 2009 The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation Nat Immunol 10 595 602 10.1038/ni.1731 19412181 1:CAS:528:DC%2BD1MXltlSrsbY%3D
60. I Sereti H Imamichi V Natarajan T Imamichi MS Ramchandani Y Badralmaa, et al. 2005 In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients J Clin Invest 115 1839 1847 10.1172/JCI24307 15937547 1:CAS:528:DC%2BD2MXlvF2qt7w%3D (Pubitemid 40979722)
61. A Cruz SA Khader E Torrado A Fraga JE Pearl J Pedrosa, et al. 2006 Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection J Immunol 177 1416 1420 16849446 1:CAS:528:DC%2BD28XmvFCmt7k%3D
62. NJ Wilson K Boniface JR Chan BS McKenzie WM Blumenschein JD Mattson, et al. 2007 Development, cytokine profile and function of human interleukin 17-producing helper T cells Nat Immunol 8 950 957 10.1038/ni1497 17676044 1:CAS:528:DC%2BD2sXptlSku7o%3D (Pubitemid 47300009)